Skip to content

AKNA drives neuroblastoma cell fate transition through chromatin modifications of stemness factors and differentiation by cytosolic retention.

Jul 2026 · Biochimica et biophysica acta. Molecular cell research · Vol 1873, pp. 120192 · 0 citations · 90 references
Medicine

TL;DR

Findings establish AKNA as a critical regulator of neuroblast cell fate determinants in association with epigenetic modifiers and signaling pathways, offering potential targets for neuroblastoma therapies and regenerative medicine for neurodegenerative diseases.

Abstract

Neuroblast cells play a pivotal role in adult neurogenesis. However, the detailed mechanisms underlying the acquisition of pluripotency or the process of differentiation remain unknown. Herein, the role of the AT-hook protein AKNA in regulating pluripotency and stemness in neuroblastoma cells is demonstrated through gene knockdown, immunofluorescence, chromatin immunoprecipitation (ChIP), localization of AKNA, signaling interactions, and transcriptional activity. AKNA was detected primarily in the nucleus during the induction of pluripotency and was retained in the cytosol by FAK signaling during differentiation. Loss of AKNA disrupts both the stemness and differentiation potential of neuroblastoma cells. In the nucleus, colocalization and physical association between AKNA and KDM6B promote H3K27me3 demethylation and subsequently H3K27ac deposition on the promoters of stemness genes, triggering their transcription. These findings establish AKNA as a critical regulator of neuroblast cell fate determinants in association with epigenetic modifiers and signaling pathways, offering potential targets for neuroblastoma therapies and regenerative medicine for neurodegenerative diseases.

View source

Similar papers

Open access Aug 2026

TUG1 supports mouse two-cell-stage development and ZGA-associated transcription through MAPK8 signaling

It is demonstrated that TUG1, which is highly expressed in tumors, regulates early embryonic development in mice and is transformed from a cancer-specific effector to a critical regulator of the ZGA, raising the possibility that related regulatory principles may operate in other biological contexts.

Jian-Wu Wang, Guang Yang, Qingbo Yang et al. · 0 citations
#gene editing Open access Oct 2026

Dynamic phosphorylation of DGCR8 regulates embryonic stem cell differentiation and microprocessor function

The Microprocessor complex, minimally composed of DROSHA and DGCR8, is ubiquitously required for microRNA biogenesis. It also regulates the balance between pluripotency and differentiation through mRNA alternative splicing and mRNA cleavage. However, how these various activities are regulated remains incompletely under...

K. Leong, Lawrence Mok, Karen Gu et al. · 0 citations
Open access Sep 2026

ESRRB: from embryonic development to cancer

Understanding ESRRB’s dual functions in development and tumorigenesis could provide valuable insights into mechanisms of plasticity and identify novel therapeutic targets for cancers with high adaptability.

Emma Rocaboy, Shiva Ghadiri, Yoshiaki Tanaka · 0 citations
Open access Aug 2026

Faf2 is required for neural differentiation in embryonic neural progenitor cells

It is shown that knocking out Faf2 in neural progenitor cells results in increased ER stress signature at the protein and transcription level, indicating a conserved functional role in neural progenitor cells.

A. Kakebeen, Leo F. Dunphy, Heather K. Hazen et al. · 0 citations
Open access Aug 2026

Dual-mode SOX2 regulation by miR-150 via mRNA suppression and autophagy controls stem cell fate

A role for miR-150 deficiency in biasing ectoderm–mesoderm lineage specification in hPSCs is defined and SOX2 is identified as a key downstream node regulated primarily through altered mRNA stability, with additional involvement of an autophagy-associated pathway.

Xing Zhen, Hyebin Koh, Dong-Seok Lee et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.